Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Smith & Nephew Reorganization May Foreshadow Imminent Zimmer Purchase

This article was originally published in The Gray Sheet

Executive Summary

Smith & Nephew's recently announced corporate restructuring plan portends a possible acquisition of Bristol Myers Squibb's $1.8 bil. Medical Devices Group, which includes the Zimmer orthopedics and Convatec wound management businesses.

You may also be interested in...

Exogen Acquisition Gives Smith & Nephew Ultrasound Fracture Product

Smith & Nephew will add a non-invasive ultrasound fracture healing system to its orthopedic product line through the purchase of Piscataway, New Jersey-based Exogen. A definitive agreement for the $68 mil. cash deal was announced July 26.

Novartis In Line For Ofatumumab MS Approval In June

Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts